Matisse Pharmaceuticals
CompanyGeleen, Netherlands· Pharma
Dutch biotech developing a sepsis treatment.
Minutes holds 1 development and 1 deal naming Matisse Pharmaceuticals, recorded from September 2026.
Intelligence
Investors in rounds covered by Minutes
Deals in Minutes
| Company | Deal | Amount | Counterparties | Date ↓ | Status |
|---|---|---|---|---|---|
| Matisse PharmaceuticalsHealthcare | FundingSeries A | €14M | Investors Brightlands Venture Partners, LIOF | 17 Sep | Closed |
- FundingSeries A, with Brightlands Venture Partners +1Healthcare · 17 Sep · Closed